A Framework for Estimating the Eligible Patient Population for New Migraine Acute Therapies in the United States.

ABSTRACT:

Introduction

Migraine is associated with considerable disability for patients not adequately managed with current standards of care. New acute therapies may offer relief for this population of patients; however, population size and associated potential costs of new therapies are unclear. In this study, a conceptual framework was developed to estimate anticipated use of new acute therapies.

Methods

Targeted literature review (TLR) was conducted to identify factors affecting access to migraine-specific acute therapies, and characteristics of individuals who would be eligible for new acute therapies. Findings from the TLR were combined to create a framework for estimating the size of the eligible patient population. This framework was used to calculate two estimates of the elig

SUBMITTER: Harris L 

PROVIDER: S-EPMC8478730 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature